Success Metrics

Clinical Success Rate
100.0%

Based on 33 completed trials

Completion Rate
100%(33/33)
Active Trials
2(5%)
Results Posted
27%(9 trials)

Phase Distribution

Ph phase_1
20
53%
Ph phase_2
5
13%
Ph phase_4
3
8%
Ph early_phase_1
1
3%
Ph not_applicable
6
16%
Ph phase_3
1
3%

Phase Distribution

21

Early Stage

5

Mid Stage

4

Late Stage

Phase Distribution36 total trials
Early Phase 1First-in-human
1(2.8%)
Phase 1Safety & dosage
20(55.6%)
Phase 2Efficacy & side effects
5(13.9%)
Phase 3Large-scale testing
1(2.8%)
Phase 4Post-market surveillance
3(8.3%)
N/ANon-phased studies
6(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

97.1%

33 of 34 finished

Non-Completion Rate

2.9%

1 ended early

Currently Active

2

trials recruiting

Total Trials

38

all time

Status Distribution
Active(3)
Completed(33)
Terminated(1)
Other(1)

Detailed Status

Completed33
Recruiting2
unknown1
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
38
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.8%)
Phase 120 (55.6%)
Phase 25 (13.9%)
Phase 31 (2.8%)
Phase 43 (8.3%)
N/A6 (16.7%)

Trials by Status

unknown13%
completed3387%
not_yet_recruiting13%
withdrawn13%
recruiting25%

Recent Activity

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT04746989

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines - (DREAM) Probenecid vs Allopurinol

Completed
NCT04551222Phase 2

The Re-Prosper HF Study

Completed
NCT07318870Phase 2

Efficacy of Probenecid on Cluster Seizures During Anti Seizure Medication Withdrawal in Presurgical Focal Epilepsy Video-EEG Monitoring

Not Yet Recruiting
NCT05611905

Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid

Completed
NCT07160738Phase 1

A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060

Recruiting
NCT04939623Phase 2

Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal

Recruiting
NCT06416800Phase 1

A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants

Completed
NCT05082909Phase 1

Addition of Probenecid to Penicillin-V Therapy

Completed
NCT06647810Phase 1

A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood

Completed
NCT05954624Phase 1

Drug-durg Interaction of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and Probenecid

Completed
NCT03307252Phase 1

This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men

Completed
NCT05497674Phase 1

Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects

Completed
NCT02243631Early Phase 1

Effect of Probenecid on Synovial Fluid ATP Levels in CPPD

Completed
NCT05280054Phase 1

AV-101 Alone and in Combination With Probenecid in Healthy Subjects

Unknown
NCT00000670Not Applicable

Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks

Completed
NCT00000706Not Applicable

Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine

Completed
NCT00000881Phase 1

A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease

Withdrawn
NCT00000945Not Applicable

A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients

Completed
NCT03965351Phase 4

TRPV2 Agonists in the Fontan Circulation

Completed
NCT03296800Phase 1

Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects

Completed

Drug Details

Intervention Type
DRUG
Total Trials
38